• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对于非整倍体游离DNA筛查结果为阴性的女性,孕11至14周超声检查有何作用?

What is the role of the 11- to 14-week ultrasound in women with negative cell-free DNA screening for aneuploidy?

作者信息

Reiff Emily S, Little Sarah E, Dobson Lori, Wilkins-Haug Louise, Bromley Bryann

机构信息

Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA, USA.

Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, USA.

出版信息

Prenat Diagn. 2016 Mar;36(3):260-5. doi: 10.1002/pd.4774. Epub 2016 Feb 5.

DOI:10.1002/pd.4774
PMID:26748490
Abstract

OBJECTIVE

This study aimed to examine the role of the 11- to 14-week ultrasound in women with negative cell-free DNA screening.

METHODS

A retrospective cohort study of women at increased risk for aneuploidy based on age or medical history and negative cell-free DNA screening between March 2012 and March 2014 was conducted. Patients were included if they had an 11- to 14-week ultrasound and obstetrical care at our center(s). Primary outcome was an unexpected finding at ultrasound. Imaging findings were compared with obstetrical outcome by medical record review.

RESULTS

Study group was composed of 1739 patients. An unexpected finding was identified in 60/1739 (3.5%). An abnormal fetal finding occurred in 37 living fetuses (2.1%); 33 had a nuchal translucency (NT) ≥ 3 mm, including four 'isolated' cystic hygroma and three with a structural abnormality. Four fetuses had a structural anomaly without a thick NT. Karyotype confirmed euploidy in 98.7% of available cases. Pregnancy termination was chosen by 63.6% of those with cystic hygroma or anomaly at the 11- to 14-week scan. Unexpected multiples were identified in 13 (0.7%) women and a fetal demise in 10 (0.6%).

CONCLUSION

Unexpected findings at the 11- to 14-week scan occur in 3.5% of patients with negative cell-free DNA. Recognition provides options for comprehensive testing, consultation, and management.

摘要

目的

本研究旨在探讨11至14周超声检查在无细胞DNA筛查结果为阴性的女性中的作用。

方法

对2012年3月至2014年3月期间因年龄或病史而患非整倍体风险增加且无细胞DNA筛查结果为阴性的女性进行了一项回顾性队列研究。如果患者在我们中心接受了11至14周的超声检查和产科护理,则纳入研究。主要结局是超声检查中意外发现的情况。通过病历审查将影像学检查结果与产科结局进行比较。

结果

研究组由1739例患者组成。在1739例中有60例(3.5%)发现了意外情况。37例存活胎儿(2.1%)出现了异常胎儿情况;33例颈部透明带(NT)≥3mm,包括4例“孤立性”囊状水瘤和3例伴有结构异常的情况。4例胎儿有结构异常但NT不厚。在98.7%的可用病例中,核型证实为整倍体。在11至14周扫描时发现囊状水瘤或异常的患者中,63.6%选择了终止妊娠。13例(0.7%)女性发现了意外的多胎妊娠,10例(0.6%)发现了胎儿死亡。

结论

在无细胞DNA筛查结果为阴性的患者中,11至14周扫描时意外发现的情况发生率为3.5%。识别这些情况为全面检查、咨询和管理提供了选择。

相似文献

1
What is the role of the 11- to 14-week ultrasound in women with negative cell-free DNA screening for aneuploidy?对于非整倍体游离DNA筛查结果为阴性的女性,孕11至14周超声检查有何作用?
Prenat Diagn. 2016 Mar;36(3):260-5. doi: 10.1002/pd.4774. Epub 2016 Feb 5.
2
Utility of ultrasound examination at 10-14 weeks prior to cell-free DNA screening for fetal aneuploidy.在进行游离DNA筛查胎儿非整倍体之前10至14周时超声检查的效用。
Ultrasound Obstet Gynecol. 2017 Apr;49(4):465-469. doi: 10.1002/uog.15995. Epub 2017 Mar 1.
3
First trimester contingent testing with either nuchal translucency or cell-free DNA. Cost efficiency and the role of ultrasound dating.孕早期采用颈部透明带或游离DNA进行偶然检测。成本效益及超声孕周测定的作用。
Acta Obstet Gynecol Scand. 2015 Apr;94(4):368-75. doi: 10.1111/aogs.12579. Epub 2015 Feb 17.
4
Fetal karyotyping after 28 weeks of gestation for late ultrasound findings in a low risk population.妊娠28周后对低风险人群的晚期超声检查结果进行胎儿核型分析。
Prenat Diagn. 2003 Dec 30;23(13):1068-72. doi: 10.1002/pd.715.
5
Ultrasonographic markers for chromosomal abnormalities in women with negative nuchal translucency and second trimester maternal serum biochemistry.颈部透明带阴性及孕中期母体血清生化指标正常的女性染色体异常的超声标志物
Ultrasound Obstet Gynecol. 2000 Oct;16(5):402-6. doi: 10.1046/j.1469-0705.2000.00215.x.
6
Detection of fetal structural anomalies in a basic first-trimester screening program for aneuploidy.在孕早期非整倍体基本筛查项目中检测胎儿结构异常。
J Ultrasound Med. 2014 Oct;33(10):1737-45. doi: 10.7863/ultra.33.10.1737.
7
[Clinical application of noninvasive prenatal diagnosis using cell free fetal DNA in maternal plasma].游离胎儿DNA在母体血浆中用于无创产前诊断的临床应用
Zhonghua Fu Chan Ke Za Zhi. 2012 Nov;47(11):813-7.
8
[Study on several ultrasound markers combined maternal serum biochemical markers to screen fetal chromosomal aneuploidy at 11 to 13(+)6 weeks of gestation].孕11至13⁺⁶周几种超声软指标联合母体血清生化指标筛查胎儿染色体非整倍体的研究
Zhonghua Fu Chan Ke Za Zhi. 2013 Nov;48(11):815-8.
9
First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death.孕早期超声检查及非整倍体的生化标志物与即将发生的胎儿死亡预测
Ultrasound Obstet Gynecol. 2006 Oct;28(5):637-43. doi: 10.1002/uog.3809.
10
Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.在一站式诊所中使用孕早期超声和母体血清生化指标对双胎妊娠进行21三体综合征筛查:三年经验回顾
BJOG. 2003 Mar;110(3):276-80.

引用本文的文献

1
Pregnancy outcomes of 4,200 fetuses with increased nuchal translucency in Henan, China.中国河南4200例颈部透明带增厚胎儿的妊娠结局
Front Med (Lausanne). 2025 Apr 2;12:1514504. doi: 10.3389/fmed.2025.1514504. eCollection 2025.
2
Application of non-invasive prenatal testing in screening chromosomal aberrations in pregnancies with different nuchal translucency cutoffs.无创产前检测在不同颈项透明层截断值的妊娠中筛查染色体畸变的应用。
Mol Cytogenet. 2023 Oct 28;16(1):29. doi: 10.1186/s13039-023-00661-1.
3
Cost-effectiveness of ultrasound before non-invasive prenatal screening for fetal aneuploidy.
超声检查在非侵入性产前筛查胎儿非整倍体中的成本效益。
Ultrasound Obstet Gynecol. 2023 Mar;61(3):325-332. doi: 10.1002/uog.26100.
4
Different Cutoff Values for Increased Nuchal Translucency in First-Trimester Screening to Predict Fetal Chromosomal Abnormalities.孕早期筛查中用于预测胎儿染色体异常的颈项透明层增厚的不同截断值
Int J Gen Med. 2021 Nov 18;14:8437-8443. doi: 10.2147/IJGM.S330960. eCollection 2021.
5
Patient-friendly integrated first trimester screening by NIPT and fetal anomaly scan.通过无创产前检测(NIPT)和胎儿畸形扫描进行的对患者友好的孕早期综合筛查。
Mol Cytogenet. 2021 Jan 9;14(1):4. doi: 10.1186/s13039-020-00525-y.
6
Automatic Fetal Middle Sagittal Plane Detection in Ultrasound Using Generative Adversarial Network.基于生成对抗网络的超声自动胎儿中矢状面检测
Diagnostics (Basel). 2020 Dec 24;11(1):21. doi: 10.3390/diagnostics11010021.
7
Analyzing false-negative results detected in low-risk non-invasive prenatal screening cases.分析低风险无创性产前筛查病例中检测到的假阴性结果。
Mol Genet Genomic Med. 2020 Apr;8(4):e1185. doi: 10.1002/mgg3.1185. Epub 2020 Feb 18.
8
The utility of nuchal translucency ultrasound in identifying rare chromosomal abnormalities not detectable by cell-free DNA screening.颈项透明层超声在识别细胞游离 DNA 筛查无法检测的罕见染色体异常中的应用。
Prenat Diagn. 2020 Jan;40(2):185-190. doi: 10.1002/pd.5583. Epub 2019 Dec 2.
9
The Use of Ultrasound as a Potential Adjunct to Cell-Free Fetal DNA Screening for Aneuploidy at Weill Cornell Medical College, New York, USA.美国纽约威尔康奈尔医学院将超声作为游离胎儿DNA非整倍体筛查潜在辅助手段的应用
Surg J (N Y). 2018 Feb 9;4(1):e1-e6. doi: 10.1055/s-0038-1624564. eCollection 2018 Jan.
10
Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women.基于基因组学的非侵入性产前检测用于检测孕妇胎儿染色体非整倍体。
Cochrane Database Syst Rev. 2017 Nov 10;11(11):CD011767. doi: 10.1002/14651858.CD011767.pub2.